Nebius Stock: A 9% Nvidia-Fuelled Pop, Two Cut Targets, and the 2027 Revenue Handover That Still Has to Happen
Published on 11/18/2026 at 17:40 | Editorial boerse-global.deNebius shares climbed 9.0% on Wednesday morning after Nvidia posted a stronger-than-expected quarterly report, extending the after-hours rally that swept through AI infrastructure and neocloud names the previous evening. The move is a sector impulse, not a fresh company announcement — and that distinction matters, because the two forces now shaping the Nebius story pull in opposite directions. Industry demand signals are running hot. Analyst price targets are heading south.
Nvidia reported revenue of $115.8 billion for the third quarter of its fiscal 2027, with guidance of $130.0 billion for the closing quarter, a forecast carrying a band of plus or minus 3%. Both the quarterly result and the outlook beat expectations, and AI cloud stocks duly gained after hours, Nebius among them. What Nvidia's numbers provide is a reference point for expectations across AI infrastructure. They do not settle what valuation Nebius itself deserves.
Two Houses, One Direction, Different Conviction
Citigroup's Tyler Radke cut his Nebius price target to $215 from $265 on Monday, according to media reports, while keeping his buy rating. The pairing is the telling part: the house lowered its valuation without abandoning its positive stance. A buy rating, in other words, is not a promise that the previous growth trajectory holds intact — and a lower target does not mean the long-term case has been thrown out. What separates the two signals is the question of which operational progress could justify the valuation from here.
D.A. Davidson went considerably further on 13 November. Analyst Gil Luria halved his target to $125 from $250 and left his rating at Neutral. Set against Citigroup, the gap shows how differently growth potential and execution risk can be weighted. The two firms share the direction of their revisions, not their verdict on the stock's appeal. Anyone watching only Wednesday's gain misses that second layer entirely.
The Revenue That Slipped — and Where It Went
The central test for Nebius is whether revenue the company no longer expects this fiscal year actually materialises. Late last week the group said part of it would shift into the early part of next year, and it guided full-year revenue to the bottom of its prior $3.0 billion to $3.4 billion range. Bloomberg reported the trimmed expectation as the trigger for the post-earnings slide in the share price.
Should investors sell immediately? Or is it worth buying Nebius?
That puts the lever somewhere other than growth rate alone. Just as important is how reliably Nebius can assign expected revenue to a given period. Should the deferred sales land as announced, it would amount to operational confirmation of the company's explanation. Further slippage would call its planning reliability into question once more — and simply repeating high growth rates would not fully dispel that uncertainty.
A 571% Quarter and the Numbers Beneath It
The bull case rests on momentum already on the books. In its third-quarter 2026 report, Nebius posted revenue of $980.8 million, up 571% year on year. Adjusted EBITDA came in at $465.8 million, alongside a net loss from continuing operations of $37.5 million. Adjusted EBITDA and the bottom line are different measures, and a sound reading holds both side by side rather than drawing a verdict from a single figure.
Financing belongs in that same picture. Data Center Dynamics reported contracts totalling $12 billion, and CEO Arkady Volozh said customer prepayments fully cover the associated capital expenditure. That addresses something more concrete than general AI enthusiasm: how contractually committed business gets funded.
Capex, Credibility and the 2027 Deadline
The sceptical reading fastens onto the link between deferred revenue and a rising spending plan. Reuters reported last week that Nebius raised expected 2026 capital expenditure to roughly $27 billion, and flagged outlays of $40 billion to $45 billion for 2027. Until capacity arrives as scheduled, the economic payoff of the buildout stays uncertain. The risk is not merely a lower sales forecast — investors must also weigh whether the pace of spending and the realisation of additional revenue fit together closely enough.
If Nebius can contain the delays and recover the expected sales, the optimistic interpretation holds: the buildout becomes the foundation for further growth. A second deferral would strip the "temporary timing issue" explanation of its persuasive force.
The next hard operational checkpoint is the announced revenue catch-up in the early part of 2027, with progress reports on the affected capacity potentially offering clues before then. What counts is not a restated intention but demonstrable progress in execution. For shareholders, the trade-off is plain: the upside sits in realising revenue already promised, the risk in further slippage arriving alongside a hefty investment programme. Price targets offer orientation along the way. They are no substitute for the operational proof.
Ad
Nebius Stock: New Analysis - 18 November
Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
